Show simple item record

dc.contributor.authorGirotti, Alessandra
dc.contributor.authorEscalera Anzola, Sara 
dc.contributor.authorAlonso Sampedro, Irene
dc.contributor.authorGonzález Valdivieso, Juan
dc.contributor.authorArias Vallejo, Francisco Javier 
dc.date.accessioned2023-03-02T08:37:49Z
dc.date.available2023-03-02T08:37:49Z
dc.date.issued2020
dc.identifier.citationPharmaceutics, 2020, Vol.12, Nº. 11, 1115es
dc.identifier.issn1999-4923es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/58816
dc.descriptionProducción Científicaes
dc.description.abstractBiomaterials science is one of the most rapidly evolving fields in biomedicine. However, although novel biomaterials have achieved well-defined goals, such as the production of devices with improved biocompatibility and mechanical properties, their development could be more ambitious. Indeed, the integration of active targeting strategies has been shown to allow spatiotemporal control of cell–material interactions, thus leading to more specific and better-performing devices. This manuscript reviews recent advances that have led to enhanced biomaterials resulting from the use of natural structural macromolecules. In this regard, several structural macromolecules have been adapted or modified using biohybrid approaches for use in both regenerative medicine and therapeutic delivery. The integration of structural and functional features and aptamer targeting, although still incipient, has already shown its ability and wide-reaching potential. In this review, we discuss aptamer-functionalized hybrid protein-based or polymeric biomaterials derived from structural macromolecules, with a focus on bioresponsive/bioactive systems.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBiomaterialses
dc.subjectBiomedicinaes
dc.subjectBiopolymerses
dc.subjectPolymers in medicinees
dc.subject.classificationAptamerses
dc.titleAptamer-functionalized natural protein-based polymers as innovative biomaterialses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2020 The Authorses
dc.identifier.doi10.3390/pharmaceutics12111115es
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/12/11/1115es
dc.identifier.publicationfirstpage1115es
dc.identifier.publicationissue11es
dc.identifier.publicationtitlePharmaceuticses
dc.identifier.publicationvolume12es
dc.peerreviewedSIes
dc.description.projectMinisterio de Economía, Industria y Competitividad - Fondo Europeo de Desarrollo Regional - Fondo Social Europeo (Proyects MAT2016-79435-R, DTS19/00162, and PID2019-106386RB-I00)es
dc.description.projectJunta de Castilla y León (Project VA317P18)es
dc.identifier.essn1999-4923es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco2403 Bioquímicaes
dc.subject.unesco2302.21 Biología Moleculares


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record